Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 3Breast 2Thoracic 1Other hematologic neoplasm 1Other 1

Conditions

Stomach Neoplasms 2Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 228Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Nutritional Support × Gastrointestinal × Clear all
NCT05714878 2024-05-10

Multimodal Prehabilitation for Resectable Gastric Cancer

Chinese PLA General Hospital

Phase NA Completed
70 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01248299 2019-05-16

E-DIS

Centre Oscar Lambret

Phase 2 Terminated
105 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02780921 2017-01-25

PREHAB

University Hospital, Clermont-Ferrand

Phase 3 Unknown
120 enrolled
Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡